Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
An observational study tracking the clinical course of patients with IgA nephropathy.
The aim is to monitor the clinical progression of patients with histologically confirmed IgA nephropathy in terms of GFR and proteinuria.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with IgA Nephropathie and a therapy with Sparsentan |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sparsentan | Drug | Follow up observation of patients with IgA Nephropathy on sparsentan regarding Albuminuria and GFR |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change of Albuminuria | What is the impact of sparsentan on Albuminuria | 36 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with IgA Nephropathy and therapy with sparsentan
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Andi Schleich | Contact | +41 44 416 21 55 | Andreas.schleich@stadtspital.ch |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stadtspital Zurich | Zurich | Canton of Zurich | 8000 | Switzerland |
according to patients wishes
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005922 | Glomerulonephritis, IGA |
| ID | Term |
|---|---|
| D005921 | Glomerulonephritis |
| D009393 | Nephritis |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C000634424 | sparsentan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| sparsentan | Drug | follow up observation of Albuminuria and GFR in IgA patients in therapy with sparsentan |
|
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |